Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women:
- 1 August 2000
- Vol. 27 (2) , 283-286
- https://doi.org/10.1016/s8756-3282(00)00325-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapyBone, 2000
- Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary IndicesJournal of Bone and Mineral Research, 1999
- Effects of the Circadian Variation in Serum Cortisol on Markers of Bone Turnover and Calcium Homeostasis in Normal Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 1998
- Measurement of Bone Degradation Products in Serum Using Antibodies Reactive with an Isomerized Form of an 8 Amino Acid Sequence of the C-Telopeptide of Type I CollagenJournal of Bone and Mineral Research, 1997
- Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up StudyBone, 1996
- Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinksJournal of Bone and Mineral Research, 1994
- Can urinary pyridinium crosslinks and urinary oestrogens predict bone mass and rate of bone loss after the menopause?European Journal of Clinical Investigation, 1992
- Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal womenJournal of Bone and Mineral Research, 1992
- Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosisJournal of Clinical Endocrinology & Metabolism, 1992
- Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosisJournal of Bone and Mineral Research, 1991